"Erythema Nodosum" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.
| Descriptor ID |
D004893
|
| MeSH Number(s) |
C17.800.174.600.375 C17.800.229.413 C20.543.206.380.375 C25.100.468.380.375
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Erythema Nodosum".
Below are MeSH descriptors whose meaning is more specific than "Erythema Nodosum".
This graph shows the total number of publications written about "Erythema Nodosum" by people in this website by year, and whether "Erythema Nodosum" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Erythema Nodosum" by people in Profiles.
-
A United States expert consensus to standardise definitions, follow-up, and treatment targets for extra-intestinal manifestations in inflammatory bowel disease. Aliment Pharmacol Ther. 2022 05; 55(9):1179-1191.
-
Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients. J Cutan Pathol. 2017 Dec; 44(12):1080-1086.
-
Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients. Inflamm Bowel Dis. 2014 Mar; 20(3):525-33.
-
Cutaneous manifestations of Hodgkin's disease. Int J Dermatol. 2006 Mar; 45(3):251-6.
-
Potential novel uses of thalidomide: focus on palliative care. Drugs. 2000 Aug; 60(2):273-92.
-
Concurrent Sweet's syndrome and erythema nodosum: a report, world literature review and mechanism of pathogenesis. J Rheumatol. 1992 May; 19(5):814-20.